Champlain Investment Partners, LLC Atri Cure, Inc. Transaction History
Champlain Investment Partners, LLC
- $13 Billion
- Q1 2025
A detailed history of Champlain Investment Partners, LLC transactions in Atri Cure, Inc. stock. As of the latest transaction made, Champlain Investment Partners, LLC holds 2,137,963 shares of ATRC stock, worth $68.2 Million. This represents 0.53% of its overall portfolio holdings.
Number of Shares
2,137,963
Previous 2,528,614
15.45%
Holding current value
$68.2 Million
Previous $77.3 Million
10.75%
% of portfolio
0.53%
Previous 0.51%
Shares
23 transactions
Others Institutions Holding ATRC
# of Institutions
238Shares Held
51.9MCall Options Held
32.6KPut Options Held
4.5K-
Vanguard Group Inc Valley Forge, PA4.71MShares$150 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$147 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY3.68MShares$117 Million0.05% of portfolio
-
Hood River Capital Management LLC Palm Beach Gardens, FL3MShares$95.7 Million1.84% of portfolio
-
Macquarie Group LTD Australia, C32.44MShares$77.8 Million0.1% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.48B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...